Marek Nowak

281/289 Rzgowska Str
Lodz, LD 93338, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Preoperative differential diagnosis - uterine sarcoma or myoma?

Preoperative differential diagnosis - uterine sarcoma or myoma?

Journal: Przeglad menopauzalny = Menopause review

Published: July 11, 2025

MiRNAs as Regulators of Immune Cells in the Tumor Microenvironment of Ovarian Cancer.

MiRNAs as Regulators of Immune Cells in the Tumor Microenvironment of Ovarian Cancer.

Journal: Cells

Published: June 24, 2024

Rapidly growing uterine myoma - should we be afraid of it?

Rapidly growing uterine myoma - should we be afraid of it?

Journal: Przeglad menopauzalny = Menopause review

Published: February 08, 2023

Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.

Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.

Journal: Experientia supplementum (2012)

Published: February 15, 2022

The implication of IL-6 in the invasiveness and chemoresistance of ovarian cancer cells. Systematic review of its potential role as a biomarker in ovarian cancer patients.

The implication of IL-6 in the invasiveness and chemoresistance of ovarian cancer cells. Systematic review of its potential role as a biomarker in ovarian cancer patients.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: July 20, 2021

The use of CA125, human epididymis protein 4 (HE4), risk of ovarian malignancy algorithm (ROMA), risk of malignancy index (RMI) and subjective assessment (SA) in preoperative diagnosing of ovarian tumors.

The use of CA125, human epididymis protein 4 (HE4), risk of ovarian malignancy algorithm (ROMA), risk of malignancy index (RMI) and subjective assessment (SA) in preoperative diagnosing of ovarian tumors.

Journal: Ginekologia polska

Published: April 21, 2021

Analysis of the results of invasive diagnostic procedures in patients referred to gynecologic department due to abnormal uterine bleeding.

Analysis of the results of invasive diagnostic procedures in patients referred to gynecologic department due to abnormal uterine bleeding.

Journal: Przeglad menopauzalny = Menopause review

Published: July 15, 2020

The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer.

The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer.

Journal: Cells

Published: April 23, 2020

Chemokine expression in patients with ovarian cancer or benign ovarian tumors.

Chemokine expression in patients with ovarian cancer or benign ovarian tumors.

Journal: Archives of medical science : AMS

Published: May 09, 2019

Adenosine Analogues as Opposite Modulators of the Cisplatin Resistance of Ovarian Cancer Cells.

Adenosine Analogues as Opposite Modulators of the Cisplatin Resistance of Ovarian Cancer Cells.

Journal: Anti-cancer agents in medicinal chemistry

Published: October 15, 2018

Analysis of preoperative blood platelet parameters in terms of diversity of epithelial ovarian cancer.

Analysis of preoperative blood platelet parameters in terms of diversity of epithelial ovarian cancer.

Journal: Medicine

Published: March 22, 2018

Clinical significance of miRNA-21, -103, -129, -150 in serous ovarian cancer.

Clinical significance of miRNA-21, -103, -129, -150 in serous ovarian cancer.

Journal: Archives of gynecology and obstetrics

Published: March 31, 2017

Showing 1-12 of 31

Last Updated: 09/26/2026